Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Business Insurance: Workers comp sector braces for surge in mental health claims
The stress of the coronavirus pandemic may cause mental health-related workers compensation claims to rise, particularly among health care wo
5 COVID-19 Security Threats to Know About
The COVID-19 pandemic has brought about a variety of security challenges for companies and individuals around the world.
Using the ODG’s Treatment Analyzer on Outcomes to Improve RTW
Workers’ comp professionals rely on the Official Disability Guidelines (ODG) to help guide the return-to-work process for injured employees. And one of the ways ODG has helped boost this effort is through its Treatment Analyzer on Outcomes or TAO Index. In today’s Inside Workers’ Comp, Mariellen Blue joins us to explain the ins and outs of TAO.
COVID-19-Related State Budget Shortfalls and Resulting Impacts to Workers’ Comp
The economic impacts associated with COVID-19 have been far-reaching and headline-grabbing: “Record levels of unemployment”, “Shuttered businesses”, “Idled and furloughed workers”. Economists have struggled to predict “What’s next?” (both short and long-term) amid an ever-shifting backdrop of varying virus case numbers, differing public policy/governmental responses, and unsettled consumer demand.
How QA Can Make or Break Your IME
The independent medical exam is a valuable tool to move claims forward. But even the slightest error in the review process can make a big difference. In today’s Inside Workers’ Comp, Donna Bradshaw, vice president of IME services at Genex, explains why a strong quality assurance (QA) program is vital to any IME service.
How COVID-19 Presumption Laws Might Affect the Workers' Compensation Industry
The COVID-19 pandemic has brought the discussion of presumption laws to the forefront, as states examine whether workers’ compensation should cover workers if they contract COVID-19 on the job. Many states have passed legislation or executive orders requiring insurers to cover essential workers who test positive for the virus. Depending on the state, the definition of “essential worker” might be limited to just healthcare and frontline workers, or it may include a wide range of occupations.